CENTER OF BIOMEDICAL RESEARCH EXCELLENCE (COBRE)

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 在过去的一年里，科布雷的TNPRC部分包括1)给Kaushal博士的一个主要项目，2)Bapi Pahar博士的一个试点项目，以及3)Pahar博士的一个主要项目，该项目是在他的试点项目结束时开始的。最后，毕业于科布雷的克里斯蒂安·阿佩特雷博士和安德鲁·麦克莱恩继续参与科布雷的工作。 Kaushal博士的项目名为：结核分枝杆菌Sigma H及其在结核病免疫病理学中的调节。 Pahar博士的项目名为：抗原特异性IgA反应在控制SIV/SIV感染中的重要性。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. During the last year the TNPRC Portion of the COBRE has consisted of 1) a major project to Dr. Kaushal, 2) a pilot project to Dr. Bapi Pahar and 3) a major project to Dr. Pahar that began when his pilot project ended. Lastly, Dr. Cristian Apetrei and Andrew MacLean who "graduated" from the COBRE continue to be involved in the COBRE. Dr. Kaushal's project is entitled: Mycobacterium tuberculosis sigma H and its regulon in the immunopathology of Tuberculosis. Dr. Pahar's project is entitled: Importance of antigen specific IgA responses in controlling SIV/SHIV infection.